Show simple item record

dc.contributor.authorCoyer, F
dc.contributor.authorCampbell, J
dc.contributor.authorDoubrovsky, A
dc.date.accessioned2021-03-09T02:57:22Z
dc.date.available2021-03-09T02:57:22Z
dc.date.issued2020
dc.identifier.issn1527-7941
dc.identifier.doi10.1097/01.ASW.0000666904.35944.a3
dc.identifier.urihttp://hdl.handle.net/10072/402984
dc.description.abstractOBJECTIVE To determine the feasibility of an adequately powered trial testing a long-acting cyanoacrylate skin protectant to prevent incontinence-associated dermatitis in critically ill patients. METHODS This open-label pilot randomized controlled feasibility study was conducted in the adult ICU of an Australian quaternary referral hospital. Patients were allocated to either an intervention group or a control group (usual care). The intervention was the application of a skin protectant (a durable, ultra-thin, transparent, waterproof, no-removal barrier film). Data collected by trained research nurses included demographic and clinical variables, skin assessment, and incontinence-associated dermatitis presence and severity. Data were analyzed using descriptive and inferential statistics. RESULTS Of the 799 patients screened, 85% were eliminated because of a short ICU stay or other exclusion criteria. The mean proportion of patients not meeting any of the exclusion criteria was 22% on each screening day. Protocol fidelity was followed for 90% of intervention participant study days. Retention of participants was 86% (31 participants out of 36), 15 in the intervention group and 16 in the control group. Enrolled patients had a mean age of 59 years, 50% were obese, 67% were male, and 36% were smokers. Two patients (11%) in the intervention group developed incontinence-associated dermatitis, compared with three (17%) in the control group. CONCLUSIONS This study reports no significant findings between the two groups. Difficulty in recruitment and feasibility issues might be overcome with changes to inclusion criteria and study design.
dc.description.peerreviewedYes
dc.languageeng
dc.publisherOvid Technologies (Wolters Kluwer Health)
dc.relation.ispartofpagefrom375
dc.relation.ispartofpageto382
dc.relation.ispartofissue7
dc.relation.ispartofjournalAdvances in Skin and Wound Care
dc.relation.ispartofvolume33
dc.subject.fieldofresearchClinical Sciences
dc.subject.fieldofresearchNursing
dc.subject.fieldofresearchcode1103
dc.subject.fieldofresearchcode1110
dc.titleEfficacy of Incontinence-Associated Dermatitis Intervention for Patients in Intensive Care: An Open-Label Pilot Randomized Controlled Trial
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationCoyer, F; Campbell, J; Doubrovsky, A, Efficacy of Incontinence-Associated Dermatitis Intervention for Patients in Intensive Care: An Open-Label Pilot Randomized Controlled Trial, Advances in Skin and Wound Care, 2020, 33 (7), pp. 375-382
dc.date.updated2021-03-09T01:03:40Z
gro.hasfulltextNo Full Text
gro.griffith.authorCampbell, Jill L.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record